MedPath

Role of Magnesium Sulphate on Delirium after cancer surgery- A Randomized Controlled trial

Not Applicable
Conditions
Health Condition 1: D099- Carcinoma in situ, unspecified
Registration Number
CTRI/2023/10/058995
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA I-III

duration of surgery- more than 2 hours

extubation at the end of surgery

Exclusion Criteria

oPatients with preoperative neurocognitive dysfunction

oPatients not consenting to the study

oPatients who will be sent intubated to ICU

oPatients who are allergic to any of the study drugs

oPatients with MoCA score less than 26

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath